Clinical trial design - Towards better practices

Journal of the European Academy of Dermatology and Venereology

Volumn 19, Issue SUPPL. 1, 2005, Pages 40-42

  Correia, O ^a   Faergemann, J ^b   Nowicki, R ^c   Ro, B I ^d  

^a Centro Dermatologia Epidermis   (Portugal)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c Klinika Dermatologiczna Medical University of Warsaw   (Poland)

^d Chung Ang University   (South Korea)

Author keywords

Clinical trial design; Double blind; Evidence based; Onychomycosis; Randomized

Indexed keywords

ANTIFUNGAL AGENT; PLACEBO;

CANDIDA; CLINICAL RESEARCH; COMORBIDITY; CONSENSUS DEVELOPMENT; DISEASE PREDISPOSITION; DRUG EFFICACY; FINGERNAIL ONYCHOMYCOSIS; FOLLOW UP; HUMAN; MEDLINE; MONOTHERAPY; PATIENT SELECTION; PRIORITY JOURNAL; RELIABILITY; REVIEW; SAMPLE SIZE; TOENAIL ONYCHOMYCOSIS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; MALE; ONYCHOMYCOSIS; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 28444468109     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2005.01286.x     Document Type: Review

References (4)

1. Moher D, Schulz KF, Altman DG and the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Clin Oral Invest 2003; 7: 2-7.
2. Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 2004; 150: 537-544.
3. Gupta AK, Ryder JE, Bluhm R, Johnson A, Summerbell RC. Onychomycosis: quality of studies. J Cutan Med Surg 2003; 7: 312-316.
4. Gupta AK, Ryder J, Summerbell RC. Comparison of efficacy criteria across onychomycosis trials: need for standardization. Int J Dermatol 2003; 42: 312-315.